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Background: Sialidases, or neuraminidases, have been
implicated in the pathogenesis of many diseases, but are
also produced by many non-pathogenic bacteria. Bacterial
sialidases are very variable in size, often possessing
domains in addition to the catalytic domain. The sialidase
from the non-pathogenic soil bacterium Micromonospora
viridifaciens is secreted in two forms with molecular
weights of 41 kDa or 68 kDa, depending on the nature of
the carbohydrate used to induce expression.
Results: We report here the X-ray crystal structures of
the 41 kDa and 68 kDa forms of the sialidase from
M. viridfaciens at 1.8 A and 2.5 A resolution respectively.
In addition, we report a complex of the 41 kDa form
with an inhibitor at 2.0 A resolution, and a complex of
the 68 ka form with galactose at 2.5 A. The 41 kDa
form shows the canonical sialidase -propeller fold. The
68 kDa form possesses two additional domains, one with
an immunoglobulin-like fold that serves as a linker to the
second, which is homologous to the galactose-binding
domain of a fungal galactose oxidase.
Conclusions: The presence of the additional carbo-
hydrate-binding domain in the 68 kDa form of the bacte-
rial sialidase reported here is a further example of
a combination of carbohydrate binding and cleaving
domains which we observed in the sialidase from Vibrio
cholerae. This dual function may be common, not
only to other bacterial and parasitic sialidases, but also to
other secreted glycosidases involved in pathogenesis.
The bacterium may have acquired both the immuno-
globulin module and the galactose-binding module from
eukaryotes, as the enzyme shows a remarkable similarity
to a fungal galacose oxidase which possesses similar
domains performing different functions and assembled in
a different order.
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Introduction
Sialidases, or neuraminidases, catalyze the removal of
terminal sialic acid residues from various glycoconju-
gates, and play roles in pathogenesis, bacterial nutrition
and cellular interactions [1]. The influenza virus neu-
raminidase, which plays a role in processing progeny
virus particles from infected cells, is well characterized.
The X-ray structures of neuraminidases from several
influenza subtypes have been reported [2-7], and these
structures have been used for the rational design of a
novel inhibitor [8] which is undergoing clinical trials as
a prophylactic against influenza. Bacterial sialidases have
been implicated in many diseases, for example: gas
gangrene (Clostridium); septicaemia (Streptococcus, Pneu-
mococcus, Bacteroides, Corynebacterium); pneumonia (Strep-
tococcus); peritonitis (Clostridium, Bacteroides); meningitis
(Streptococcus B) and cholera (Vibrio cholerae) [1]. In the
parasite Trypanosoma cruzi, a novel trans-sialidase has
been characterized [9], which has been implicated in
cell attachment and immune response evasion in the
infective trypomastigote form of the parasite [10]. Many
non-pathogenic bacteria also secrete sialidases The
function of these enzymes is to scavenge host-cell sialic
acid to use as a carbon and energy source. Such a nutri-
tional role has also been found for some pathogenic
bacteria. For example, although V. cholerae sialidase plays
a defined role in pathogenesis by processing of higher-
order gangliosides to GM1 receptors for cholera toxin,
the bacterium also possesses the enzymes for metabo-
lism of sialic acid.
Sequence analysis of bacterial sialidases shows them to be
of diverse length with low sequence identity and molecu-
lar weights ranging from -40-115 kDa. There are two
motifs common among the sequences: one is the 'FRIP'
motif (Phe-Arg-Ile-Pro, or variations on this theme),
which occurs upstream of the second motif, the 'Asp-
box' (most commonly Ser/Thr-X-Asp-[X]-Gly-X-Thr-
Trp/Phe) which repeats three to five times along the
sequences [11]. Our previous studies on two bacterial
sialidases from Salmonella typhimurium and V cholerae
showed that the arginine of the FRIP motif represents
one of the catalytic triad of arginines that binds the
carboxylate group of sialic acid, and that the Asp-boxes
are remote from the active site, in topologically equiva-
lent locations. The structure of the 42 kDa sialidase from
S. typhimurium shows the same six-bladed 1-propeller
seen in the influenza virus neuraminidase, despite a
sequence identity of only 15% with the influenza enzyme
[12]. Each blade of the propeller is a four-stranded
antiparallel -sheet, with the Asp-boxes forming the turn
between the third and fourth strands of each sheet on the
periphery of the propeller. The aspartate residues of each
Asp-box are exposed to solvent and the aromatic group
of the Asp-box tucks in between adjacent sheets. The
function of these Asp-boxes is unknown: they may simply
dictate the fold, although they are apparently absent from
the influenza enzymes, or they may play a role in a pro-
tein secretory mechanism. The structure of the 83 kDa
sialidase from V cholerae revealed a central 3-propeller
catalytic domain flanked by two lectin-like domains, one
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at the N terminus and one inserted between the second
and third blades of the propeller [13]. Although no carbo-
hydrate-binding site has yet been identified in these
lectin-like wings, it is known that active V cholerae
sialidase is able to bind to cells, and we have speculated
that the lectin domains play a role in cell adhesion in the
turbulent environment of the small intestine.
The sialidase from the soil bacterium Micromonospora
viridfaciens was first purified from a bacterial culture
filtrate [14]. When colominic acid was used as an
inducer, a soluble 41 kDa sialidase was secreted. How-
ever, when milk casein was used as an inducer, a higher
molecular weight (68-72 kDa) soluble sialidase was
secreted [15]. Subsequent cloning and sequencing of the
sialidase gene from M. viridfaciens and expression in Strep-
tomyces lividans, revealed an enzyme with a molecular
weight of 68 kDa which is easily digested to 52 kDa and
41 kDa forms, most likely through attack by S. lividans
proteases [16]. All three forms, 41 kDa, 52 kDa and
68 kDa, have almost identical catalytic properties sug-
gesting that the 41 kDa form contains the catalytic
domain. The M. viridifaciens sialidase is a member of the
family 33 glycosyl hydrolases, as are the sialidases from
S. typhimurium and V cholerae, in contrast to the influenza
virus neuraminidase which belongs to family 34 [17,18].
Here we report the crystal structures of both the 41 kDa
and 68 kDa forms of the enzyme. The latter exhibits a
modular architecture which may be common to many
other sialidases.
Results and discussion
We have determined the crystal structure of the fully active
41 kDa form of the sialidase from M. viridifaciens by the
method of multiple isomorphous replacement. The struc-
ture has been refined to 1.82 A resolution with a crystallo-
graphic R-value of 17.3%. A complex of the 41 kDa form
of the enzyme with the inhibitor 2-deoxy-2,3-dehydro-
N-acetylneuraminic acid (Neu5Ac2en, DANA) has been
refined to 2.0 A with an R-value of 15.9%. We have also
determined the structure of the larger 68 kDa form of the
sialidase by molecular replacement combined with careful
weighted difference-Fourier analyses, and have refined the
structure to 2.5 A resolution with an R-value of 21.4%. A
complex of the 68 kDa form with galactose has been
refined to 2.5 A, with an R-value of 22.8%.
Protein architecture of the 41 kDa form
The enzymatically active 41 kDa fragment, with 358
residues, forms the canonical 3-propeller fold (Fig. 1) as
seen in the influenza virus neuraminidase and bacterial
sialidases from S. typhimurium and V cholerae. Superposition
of the M. viridifaciens sialidase onto other sialidase struc-
tures reveals that it has greatest similarity to the catalytic
domain of V cholerae sialidase (333 Cot atoms superimpose
with a root mean square deviation [rmsd] of 2.31 A) with
which it shares 26% sequence identity. The five Asp-boxes
of M. viridjfaciens sialidase occur in topologically equivalent
positions as observed in the other two bacterial sialidases,
namely at the turn between the third and fourth strands
of each sheet (Fig. lb). Four of the Asp-boxes have very
similar conformations, maintained by a hydrogen-bonding
Fig. 1. -propeller fold of the 41 kDa
form of M. viridifaciens sialidase.
(a) Stereo Ca trace of the 41 kDa form
(residues 47-404) viewed from above
the active site. (b) Stereoview, in the
same orientation as (a), showing the six-
bladed propeller structure with the
inhibitor Neu5Ac2en bound. The loca-
tion of the Asp-box motifs are high-
lighted as thick black turns. (Figure
drawn using MOLSCRIPT 1411.)
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network between the conserved residues of the motif, and
with the tryptophan or phenylalanine plugging into a
hydrophobic pocket between the sheet to which the Asp-
box belongs and the preceding sheet. The fifth Asp-box,
residues 289-296, deviates from the others due to substi-
tution of a tyrosine (Tyr296) for the tryptophan. This
tyrosine is able to hydrogen bond to His294 resulting in a
distortion of the loop from its normal conformation.
The Asp-box motif, therefore, appears simply to dictate
the fold and integrity of the propeller, and may not be
involved in a secretory mechanism as we proposed previ-
ously [12]. A similar motif was recently reported for a
bacterial methanol dehydrogenase, dubbed the 'trypto-
phan docking motif', which is present in a topologically
equivalent position in each sheet of an eight-bladed
[3-propeller structure [19]. However, its similarities to the
sialidase Asp-box were not noted. This may suggest
divergence from some ancestral four-stranded sheet,
which through gene duplication formed six-bladed or
eight-bladed propeller structures with different functions.
Such a scheme for the evolution of these propeller folds
has been discussed with reference to the Drosophila kelch
motif observed in seven-bladed propeller structures [20].
Bork and Doolittle [20] argue that the the seven-bladed
fungal galactose and fungal/prokaryotic glyoxal oxidases,
as well as assorted proteins containing kelch motifs, have
evolved from some early precursor which also diverged
to form the six-bladed sialidases/neuraminidases and the
eight-bladed methanol and methylamine dehydrogenases.
Active site of the 41 kDa form
The residues involved in the binding of substrate were
identified by soaking a crystal of the 41 kDa M. viridfa-
ciens sialidase in the inhibitor Neu5Ac2en, which inhibits
most sialidases at micromolar concentrations. As observed
in other sialidases, the active site is apparently rigid
because little movement of the protein occurs upon
binding inhibitor. Interactions between the protein and
the carboxylate end of the inhibitor are conserved in all
sialidase structures studied to date, both bacterial siali-
dases and the influenza virus neuraminidase [12,13], and
these are detailed below (see also Fig. 2 and Table 1).
Firstly, three arginines (Arg68, Arg276 and Arg342) form
interactions in a plane with the carboxylate group of
Neu5Ac2en. Secondly, the position of the first arginine
(Arg 68) is stabilized by a glutamic acid (Glu386) through
a hydrogen bond between the NE of the arginine and
O81 of the glutamic acid. Thirdly, a tyrosine (Tyr370)
and a glutamic acid (Glu260) hydrogen bond with each
other and sit beneath, and close to, the Cl-C2 bond of
the inhibitor. It has been suggested that this tyrosine and
glutamic acid combination is involved in the stabilization
of an oxycarbonium ion intermediate in the catalysis [21].
Fourthly, an aspartic acid (Asp92) sits above the sugar ring
Fig. 2. Inhibitor bound to the 41 kDa
form of the enzyme. (a) Stereoview of
the 2.0 A difference Fourier electron-
density map for Neu5Ac2en, contoured
at 3.5or. The refined inhibitor is super-
imposed. (b) View of the active site of
the 41 kDa form with Neu5Ac2en
drawn with grey bonds. Residues which
form hydrogen-bonding or van der
Waals interactions with the inhibitor are
shown. (Figure generated with RASTER-
3D rendering software [42,43].)
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on a loop between the second and third strands of the first
sheet. A suggested role for this residue in the influenza
enzyme, is in the stabilization of a proton-donating water
molecule involved in the hydrolysis, rather than as a direct
proton donor to the glycosidic bond [21,22].
In contrast, interactions between the protein and other
chemical groups on the inhibitor differ between the siali-
dases. In common with the sialidases from S. typhimurium
and V cholerae, M. viridifaciens sialidase has an arginine
(Arg87) and an aspartic acid (Aspl31) which interact with
the 04 hydroxyl of the inhibitor. The absence of these
interactions in the influenza virus neuraminidase produces
a pocket close to 04. Structure-based drug design, in
which the 4-hydroxyl on Neu5Ac2en has been replaced
with a guanidinium group, fills this pocket and produces
an inhibitor with close to picomolar binding affinity for
the influenza enzyme [23]. Not surprisingly, the 4-guani-
dino compound is a much poorer inhibitor of bacterial
sialidases. It is interesting to note that the 4-guanidino
inhibitor exploits a conserved glutamic acid residue in the
influenza enzyme which takes the position of the
isoleucine in the bacterial/eukaryotic FRIP motif, at
which position the influenza enzyme has a conserved REP
motif (Arg-Glu-Pro). No functional role has been assigned
to this glutamic acid in the influenza enzyme, and it raises
the possibility that the highly efficient virus could mutate
this residue without loss of function when subjected to the
new evolutionary pressure of the designed inhibitor.
The N-acetyl group of Neu5Ac2en is accommodated in
a hydrophobic pocket, as observed in the other sialidase
structures. In the M. viridifaciens enzyme, the pocket is
formed from residues Ala93, Val148, Phe155, Leul70
and Phe203. The 08 and 09 hydroxyls of the glycerol
moiety of the inhibitor form hydrogen bonds with
Asp259 which precedes the catalytic Glu260, in a similar
fashion to the pair of adjacent glutamic acid residues seen
in the influenza enzyme.
M. viridifaciens sialidase, in common with many bacterial
sialidases, can cleave ot(2--3), ot(2-46) and (2--8)
linked sialic acids [14]. S. typhimurium sialidase is unusual
in that it has a 260-fold kinetic preference for a(2--3)
linked sialic acid over cx(2->6), similar to the preference
of the influenza enzyme [24]. In the structures of siali-
dases studied to date, no binding site has been observed
for the carbohydrate group adjacent to the sialic acid
moiety in natural substrates. Variations in substrate speci-
ficity appear to be due to differences in the lengths of the
loops around the active site causing steric hindrance.
Protein architecture of the 68 kDa form
The 68 kDa form of the sialidase consists of 601 residues
arranged as three domains: first, the 41 kDa -propeller
domain (residues 47-402); second, a 1-sandwich linker
domain (residues 403-505); and third, a 1-sandwich
galactose-binding domain (residues 506-647) (Fig. 3). The
only significant structural change between the isolated
41 kDa form and the same domain in the 68 kDa form is
in residues 402-404, which move to connect to the linker
domain. Two adjacent glycine residues (Gly402, Gly403)
between the 41 kDa domain and the linker may act as a
pivot point for movement of the other two domains.
Linker domain
The linker domain (residues 403-505) possesses an
immunoglobulin (Ig) fold. The 1-sandwich comprises
four antiparallel strands over three antiparallel strands and
is reminiscent of the constant domains of immunoglobu-
lins [25] (Fig. 4a). In contrast to most Ig folds, an almost
cylindrical seven-stranded 13-barrel structure is formed,
which is stabilized by the first strand (strand a in Ig
nomenclature) forming hydrogen bonds with strands b
and g. Strand a accomplishes this feat by having a proline
halfway along (Pro411) which shifts the strand direction
Fig. 3. View of the 68 kDa form of M. viridifaciens sialidase. The
41 kDa domain is shown in yellow, the linker in red and the galac-
tose-binding domain in green. The Neu5Ac2en and galactose mol-
ecules are drawn in space-filling mode. The monovalent cation is
drawn as a grey sphere, the two glycines (Gly402, Gly403), which
may form a hinge, are drawn as purple spheres, and the proline
residue in the linker domain, which causes the first strand to
dogleg between the sheets, is drawn as a light blue sphere.
Table 1. Hydrogen-bonding interactions between M. viridi-
faciens sialidase and the inhibitor Neu5Ac2en (DANA).
Residue Atom Interacting Distance (A)
with DANA
Arg68 Nrl, Nrq2 01A 2.73, 2.91
Arg87 N'q2 04 3.03
Asp92 081 04 2.72
Aspl31 081 N5 2.96
Aspl31 082 04 2.75
Asp259 081 08 2.69
Asp259 082 09 3.11
Arg276 NYq2 01B 3.21
Arg342 NTl1 01A 2.84
Arg342 N'q2 01B 2.95
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Fig. 4. Stereoview Ca traces of the addi-
tional domains in the 68 kDa form of
the enzyme. (a) The immunoglobulin-
like linker domain (residues 403-505).
(b) The galactose-binding domain
(residues 506-647).
from the b strand to the g strand on the opposite sheet. We
compared the topology of the linker fold with the entire
April 1995 release of the Brookhaven Protein Data Bank
(PDB) using PROTEP [26]. This comparison revealed
that the linker has greatest topological similarity to several
light-chain variable regions of immunoglobulins (although
they possess two additional strands), to the C-terminal
domain of CD4, and to the N-terminal domain of the
chaperone protein PapD (PDB code 3DPA). It is interest-
ing to note that, in PapD, strand a also doglegs to form
hydrogen bonds to both strands b and g, leading to a more
cylindrical barrel similar to that in the sialidase linker.
The sialidase linker does not contain any disulphide
bonds and its sequence does not conform to consensus
patterns reported for Ig folds [25]. It therefore represents
another variation on the Ig fold. With its cylindrical
shape and well-packed hydrophobic core, its role in the
sialidase appears to be that of a rigid linker between the
other two domains.
Galactose-binding domain
The C-terminal domain of the M. viridlfaciens sialidase
(residues 506-647) shares 35.4% sequence identity with
the N-terminal domain of a fungal galactose oxidase
from Dactylium dendroides, which was found to possess a
galactose-binding site [27]. Most of the residues identi-
fied as being involved in galactose binding or cation
binding in galactose oxidase are conserved in this third
sialidase domain. The two domains are very similar in
structure and superimpose with an rmsd of 1.16 A for
139 Cot atoms. The topology is that of a P-sandwich
with a five-stranded antiparallel 13-sheet packed on top of
a three-stranded antiparallel -sheet, and can be
described as a jelly-roll (Fig. 4b). A cation, which main-
tains the conformation of a loop (residues 528-536), was
Fig. 5. Stereoview of the 2.5 A difference
Fourier electron-density map showing
the binding of galactose and its environ-
ment in the 68 kDa form of M. viridifa-
ciens sialidase. Map contoured at 3u.
(a)
ILI
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suggested to be Na+ or a similar monovalent cation in
the structure of galactose oxidase. The same ligands coor-
dinate the ion in both M. viridfaciens sialidase and galac-
tose oxidase, in a pentagonal bipyramidal configuration.
The location of the.galactose-binding site was confirmed
by soaking a crystal of the 68 kDa form in -50 mM
P-D-galactose for 4 h (Fig. 5). The major interactions
between galactose and the protein are: hydrogen bonding
of the 03 and 04 hydroxyls of galactose to Arg572;
hydrogen bonding of 04 to OEl of Glu578, and a weak
interaction between 04 and NE2 of His539; a weak
interaction with Oy of Ser575; and finally, van der Waals
interactions between C6 and Trp542. The galactose-
binding site is located -30 A directly above the active site
of the 41 kDa domain.
Biological implications
Sialidases have been implicated in the pathogenesis
of many diseases, but are also secreted by several
non-pathogenic bacteria for which they play a
nutritional role. Bacterial sialidases range in size
from 40 kDa to 115 kDa with little sequence iden-
tity between them apart from two small sequence
motifs, one of which repeats up to five times along
the sequence. The soil bacterium Micromonospora
viridifaciens secretes two forms of a sialidase, with
molecular weights of 41 kDa, and 68 kDa, depend-
ing on the substrate used to induce expression.
The 68 kDa form of the sialidase from M. viridifa-
ciens encompasses the 41 kDa catalytic, six-bladed
[-propeller domain and has two additional
domains downstream of it. One of these domains,
with the topology of an immunoglobulin module,
appears to serve solely as a rigid linker arm to the
last, galactose-binding, domain. This final domain
is homologous to the galactose-binding domain
found in a fungal galactose oxidase. Intriguingly,
the M. viridifaciens sialidase represents a variation
on a theme seen in the fungal enzyme, suggesting
that they may be related in more ways than one.
The catalytic domain of galactose oxidase has a
seven-bladed -propeller fold, with the galactose-
binding domain situated at its N terminus, and a
distorted immunoglobulin module at its C termi-
nus. It is conceivable that M. viridifaciens has
acquired the immunoglobulin and galactose-bind-
ing modules from eukaryotes such as fungi or ani-
mals. This bacterial sialidase and galactose oxidase
may also share a common ancestor in a primitive
four-stranded 13-sheet, which, through multiple
gene duplication events (as many as six or seven
times) and functional divergence, has provided two
domains with very different catalytic functions.
M. viridifaciens secretes the 41 kDa form of the
enzyme when colominic acid (poly a2-8
N-acetylneuraminic acid) is used as the inducer,
but secretes the 68 kDa form when milk casein is
used. It may be that sialic acid on the casein gly-
coproteins together with galactose, either on the
glycoproteins or the lactose 'contaminant' often
found with casein, is inducing the larger form of
the enzyme. The galactose-binding domain may
anchor the enzyme to appropriate substrates
allowing the catalytic domain to do its work.
Alternatively it may work in concert with the cat-
alytic domain in helping to feed appropriate
oligosaccharides to the active site. Such concerted
activity may require the relative movement of the
catalytic and galactose-binding domains which
appears possible around a flexible pivot point cre-
ated by a pair of consecutive glycine residues.
Our earlier discovery of two lectin-like domains in
the sialidase from Vibrio cholerae, together with the
findings presented here on the M. viridifaciens siali-
dase, suggest that this combination of catalytic
and carbohydrate domains may be common to
other members of the sialidase family. These car-
bohydrate-binding domains may play roles in cell
adhesion or targeting specific substrates, and in
the case of pathogenic bacteria may provide addi-
tional targets for therapeutic intervention.
Materials and methods
41 kDa form
Crystals of the 41 kDa form of M. viridifaciens sialidase were
grown by the hanging drop vapour diffusion method from an
8% polyethylene glycol (PEG) 3350 solution at pH 5.0 or 5.5 as
described previously [28]. The enzyme has its maximal activity
at pH 5.0 [14]. The enzyme crystallizes in space group P212121
with unit cell a=48.14 A, b=82.73 A and c=84.75 A. There is
one enzyme molecule in the asymmetric unit giving an esti-
mated solvent content of 40%. All data were collected at room
temperature (18 °) on a Siemens area detector mounted on a
rotating anode X-ray source. The programs XDS and XSCALE
were used for all data processing and reduction [29]. Inhibitor
complex data were collected from a crystal soaked for 3 h in
5 mM Neu5Ac2en (DANA). The unit cell of the inhibitor-
soaked crystals is a=48.00 A, b=82.86 A and c=84.94 A.
Initial attempts were made at molecular replacement using the
structure of S. typhimurium sialidase, with which M. viridfaciens
sialidase shares 20% sequence identity and with the catalytic
domain of V. cholerae sialidase, but these proved fruitless. The
structure was solved using three mediocre derivatives. Deriva-
tives were identified through Patterson maps and cross-phase
difference Fourier maps using the CCP4 package [30], and the
program MLPHARE [31] was used for refinement of the
heavy-atom parameters and the phases derived from them
(Table 2). A 3.0 A multiple isomorphous replacement (MIR)
map was used together with a solvent-flattened map, deter-
mined with the Wang method in the implementation of Leslie
[32], in the interpretation of the structure. In spite of a rela-
tively poor MIR map, many 3-strands were evident. Interpre-
tation was aided by a 3.0 A difference Fourier map calculated
from the inhibitor complex data. Even with the poor MIR
phases used to calculate this difference Fourier, the asymmetric
shape of the inhibitor was evident and this aided the positioning
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Table 2. X-ray data collection and phasing statistics.
41 kDa 41 kDa
CdCI2 La(ac)3
41 kDa 41 kDa 68 kDa 68 kDa with
K13 Inhibitor Native Galactose
No. of observations 168 296 24180 24 521 24577 93 040 49 584 35 106
No. of unique reflections 29469 6327 6665 6814 20366 20112 16297
Resolution (A) 1.82 3.0 3.0 3.0 2.0 2.5 2.5
Overall completeness (>1a) (%) 93.4 85.3 86.7 87.9 83.0 79.2 59.3
Overall RI (%)* 5.5 5.6 8.2 7.9 6.3 3.9 5.4
Completeness (>la) (%) 71.7 57.8 58.3 58.0 67.4 76.8 49.3
in top shell (2-1.82 A) (3.2-3 A) (3.2-3 A) (3.2-3 A) (2.5-2 A) (2.7-2.5 A) (2.7-2.5 A)
R, (%)* in top shell 9.4 8.2 14.4 13.9 11.2 9.2 11.8
Heavy-atom concentration (mM) 2 2 0.2
Soaking time (days) 2 3 10
Heavy-atom sites C, D A B
Phasing powerl(acentric, centric) 0.8, 0.6 0.7, 0.4 0.4, 0.3
Cullis R* (acentric, centric) 0.42, 0.74 0.62, 0.86 0.50, 0.93
Figure of merit is 0.40 for all 6231 reflections between 20-3 A.
*RI=E I-<I> /I<I>, where I=diffraction density. tPhasing power=rms fH/E, where fH=calculated heavy-atom structure-factor
amplitude and E=lack of closure= I FpH+F -fH I (FpH=structure-factor amplitude of derivative crystals and Fp=structure-factor
amplitude of native crystals). Cullis R=lack of closure/isomorphous difference. Sums over all reflections n.
of the homologous S. typhimunrium sialidase-inhibitor complex
model onto the M. viridifaciens sialidase MIR map. Skeletonized
representations of both the MIR and solvent-flattened maps
were computed and manually edited using the graphics package
O [33] to give a continuous Cot trace. Conserved active-site
residues in the two bacterial sialidases and the location of the
Asp-boxes served as landmarks in the interpretation.
The model was refined in X-PLOR [34] initially using data to
3.0 A. Cycles of simulated annealing refinement were followed
by manual rebuilding with O using experimental, SIGMAA-
weighted 2Fo-F c [35] and omit maps. Data to 1.82 A were
gradually included, water molecules were identified and the
whole refined to give the final model (Table 3), which contains
residues 47-404 with 270 water molecules and has an R-value
of 0.173 for all data between 6.0 A and 1.82 A. Residues 1-37
code a signal peptide, with the N terminus of the 41 kDa
product reported to start at residue 43 [16]. However, no elec-
tron density is observed for residues 43-46. The C terminus of
the 41 kDa product has not been determined chemically, but
there is no interpretable density beyond residue 404. The final
model has no residues in disallowed regions of the Ramachan-
dran plot, and a 3D-1D plot showed that all the residues are in
chemically sensible environments [36]. A Luzatti plot gave an
estimated error in atomic coordinates of 0.15-0.20 A.
A difference Fourier map was calculated with coefficients
(FNeu2Ac2en-FNative)eXP i4calc with phases calculated from the
1.82 A model after water molecules had been removed from
the active site, and clearly revealed the conformation of the
inhibitor (Fig. 2a). The protein-inhibitor complex was refined
using X-PLOR to give a final model which includes 265
water molecules with an R-value of 0.159 for all data from
6.0-2.0 A (Table 3).
68 kDa form
The 68 kDa form was successfully derived from molecular
replacement and careful difference Fourier maps, even with
data that were initially incomplete to 3.5 A. The progress of
this structure solution is therefore given in some detail.
The 68 kDa form of M. viridfaciens sialidase was purified by the
same method as the 41 kDa protein [28]. Crystals were obtained
by microseeding followed by macroseeding usifig the hanging
drop vapour diffusion method. All wells contained 0.1 M Tris
buffer pH 8.4 and 8% PEG 8000 as precipitant. The initial drop
contained 3 p.1 of protein at a concentration of 12 mg mi-', and
3 .1 of well solution. A 3 pl1 volume of a small crystal suspension
obtained from the initial drop was then dissolved in 100 pi of
the well solution and aspirated violently. Next, 1 p1 of this solu-
tion was added to 3 p1 of protein and 3 1I of new well solution.
Derivative 41 kDa
Native
Table 3. Model refinement of the 41 kDa and 68 kDa forms.
Model 41 kDa 41 kDa 68 kDa 68 kDa
Native Inhibitor complex Native Galactose complex
Number of non-hydrogen protein atoms 2701 2721 4536 4548
Number of water molecules/ions 270/0 265/0 0/1 0/1
Resolution range (A) 6.0-1.82 6.0-2.0 6.0-2.5 6.0-2.5
Number of reflections 28814 20015 18632 15102
R-factor for all data (%) 17.3 15.9 21.4 22.8
Rmsd in bond lengths (A) 0.016 0.020 0.016 0.012
Rmsd in bond angles () 2.57 2.74 2.57 1.96
Average temperature factors (A2)
main-chain/side-chain all domains 14.7/21.8 14.8/24.3 17.7/19.0
main-chain/side-chain domain 1 - - 17.3/17.6
main-chain/side-chain domain 2 - - 19.4/23.6
main-chain/side-chain domain 3 - - 17.3/19.4
inhibitor/galactose - 12.9 - 50.5
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Finally, the larger crystals obtained from this trial were washed in
successive buffers containing increasing concentrations of PEG
8000 up to 8% and macroseeded in a solution containing 1 LI of
protein and 3 jxl of well solution. Crystals with dimensions of up
to 0.4x0.1 x0.1 mm 3 were obtained.
The crystals belong to space group P21, with unit cell
a=51.1 A, b=117.1 A, c=60.0 A and 3=95.6° , giving a calcu-
lated solvent content of 53%. Crystals diffracted to only 4 A on
the in-house rotating anode source, and a low resolution set of
data was collected and processed using XDS. Molecular
replacement using the 41 kDa model was carried out with the
AMoRE package [37] which gave a clear solution for the rota-
tion and translation functions. Rigid-body refinement of the
model gave a crystallographic R-value of 0.415 using data from
10-6 A. A 6 A SIGMAA-weighted 2F-F c difference Fourier
map, calculated using phases from the partial model, clearly
showed additional electron density for the extra 27 kDa of
protein which is located downstream of the 41 kDa fragment.
At this point a partial native data set was collected at the DESY
synchrotron, Hamburg, on station X31 at a wavelength of
0.993 A, where diffraction to 2.8 A was observed. Only 540 of
data were collected from one crystal at room temperature in 10
frames which were processed using XDS. Synchrotron data
were merged with the in-house data using XSCALE to give a
reasonable working set of data to 3.5 A, which was only 57%
complete (I>u[I]) with an RI of 12.7%. Because of the paucity
of the data at this stage, the free R-factor [38] was employed
throughout the building and refinement procedures using
X-PLOR, with 5% of the reflections as the test set. The 41 kDa
domain was kept fixed throughout all subsequent refinement
and the B-factors from the 1.82 A refined 41 kDa structure
were maintained. The 41 kDa domain was rigid-body refined in
X-PLOR using data from 8-3.5 A, giving an R-value of 0.425
(Rfree=0. 44 5). A SIGMAA-weighted 2Fo-Fc difference map
was calculated using phases from this rigid-body refined partial
model, which was subjected to eight cycles of solvent-flattening
using the Leslie implementation of the Wang procedure but
with a SIGMAA-weighted difference Fourier being back-trans-
formed on each cycle. The resulting solvent-flattened map
showed distinct electron density for the extra 27 kDa of protein,
which appeared to form two domains (Fig. 6). A FastA [39]
search of the SWISSPROT database with the 27 kDa sequence
revealed a 34.6% sequence identity within a 127 amino acid
region of galactose oxidase from Dactylium dendroides, the struc-
ture of which has been elucidated [27]. The N-terminal galac-
tose-binding domain of galactose oxidase was moved manually
in O as a rigid body into the M. viridfaciens 3.5 A difference
electron-density map, and was found to fit remarkably well.
The 41 kDa domain and galactose-binding domain (with B-fac-
tors set to 15 A2) mutated to the M. viridfaciens sequence, were
refined in X-PLOR as rigid bodies. The galactose-binding
domain was then subjected to 200 cycles of positional refine-
ment. Further SIGMAA-weighted and solvent-flattened differ-
ence Fourier maps allowed tentative tracing of the intervening
domain and adjustments to the galactose-binding domain. Posi-
tional refinement of the galactose-binding domain and of a
polyalanine model for the linker domain was carried out. After
several rounds of rebuilding, all atoms of the additional domains
of the 68 kDa form were subjected to positional refinement,
with B-factors fixed at 15 A2, the 41 kDa domain still remaining
fixed, to give a final R-value of 0.249 (Rfree=0.2 97).
At this point a more complete synchrotron data set to higher
resolution was collected in Hamburg on station X31, on a
crystal which diffracted to 2.5 A. A total of 1010 of data were
collected at 40C in 1 steps. The data were integrated using the
DENZO package (Table 2) [40]. This new crystal, of dimen-
sions 0.4x0.2x0.2 mm3 had grown slowly over two months
using 4% PEG 4000 as precipitant, with an initial protein con-
centration of 12 mg ml-' in 0.1 M Tris-HCI buffer at pH 8.2.
The 3.5 A model minus the linker domain was used as the
starting model for simulated annealing refinement in X-PLOR
against this new data (6.0-2.5 A with a 2r cutoff) to give an
R-value of 0.307 (Rfree=0.42 3). A SIGMAA-weighted 2Fo-Fc
map confirmed the connectivity of the linker domain, but
allowed rebuilding of some regions which were in doubt. After
several rounds of simulated annealing refinement, rebuilding
and finally isotropic B-factor refinement, the final R-value was
0.214 (Rfree=0.340) (Table 3). The final model consists of 601
residues (47-647), and one cation arbitrarily assigned as a
sodium. There are only two residues in the disallowed region
of the Ramachandran plot, Val421 in the linker domain and
Ala545 in the galactose-binding domain, and from a 3D-1D
plot all residues are in acceptable environments. A Luzatti plot
gave an estimated error in coordinates of 0.30 A.
The previously exposed native crystal was soaked in -50 mM
P-D-galactose for 4 h, and 76 ° of data collected again on station
X31 (Table 2). A difference Fourier map calculated with coeffi-
cients (FGalactose-FNative)eXp icalc with phases calculated from
the 2.5 A model revealed electron density into which a galactose
molecule could be fitted. There was no apparent movement of
the protein side chains. A single round of positional refinement
was carried out to produce a final model with an R-value of
0.228 for all data between 6.0 A and 2.5 A (Table 3).
Atomic coordinates have been deposited in the Brookhaven
Protein Data Bank.
Fig. 6. Additional electron density for the
68 kDa form of the sialidase revealed in
a difference Fourier. Stereoview of
the 3.5 A SIGMAA-weighted, solvent-
flattened 2Fo-F c difference Fourier map
based on phases calculated from a mol-
ecular replacement solution of the
41 kDa domain only. The map is con-
toured at l. The Ca trace of the final
68 kDa model is superimposed with the
41 kDa domain in yellow and the
additional 27 kDa domains in blue.
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